feed,title,long_url,short_url
SeekingAlpha,Third dose of AstraZeneca's Vaxzevria increases antibody response against Omicron variant,https://seekingalpha.com/news/3787768,
SeekingAlpha,Lysogene announces termination of license pact with Sarepta for LYS-SAF302 Program,https://seekingalpha.com/news/3787767,
SeekingAlpha,Shipping Weekly Markets Report - 'Quiet' Period With No Major Swings,https://seekingalpha.com/article/4479469,
